- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 150 Pages
Global
From €4681EUR$4,850USD£4,016GBP
- Report
- February 2024
- 182 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- March 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- August 2022
- 120 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- January 2024
- 101 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- April 2024
- 50 Pages
Global
From €2558EUR$2,650USD£2,194GBP
- Report
- November 2023
- 215 Pages
China
From €3861EUR$4,000USD£3,312GBP
- Report
- November 2023
- 109 Pages
China
From €1737EUR$1,800USD£1,490GBP
Ramipril is a drug used to treat cardiovascular diseases, such as hypertension, congestive heart failure, and myocardial infarction. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to narrow. This helps to reduce blood pressure and improve blood flow. Ramipril is also used to reduce the risk of stroke, heart attack, and death in people with coronary artery disease. It is available in both generic and brand-name formulations.
Ramipril is a widely used drug in the cardiovascular market, with a long history of safety and efficacy. It is generally well-tolerated and has few side effects. It is also cost-effective, making it an attractive option for many patients.
Some of the companies in the Ramipril market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more